1-Methyl-3-nitro-1H-pyrazole-4-carboxylic acid, 250mg

(6-Methyl-1,2,4,5-tetrazin-3-yl)methanamine hydrochloride, 250mg

2-Chloro-5-methylcyclohexa-2,5-diene-1,4-dione, 98%, 1g

Narrow mouth bottle, 2000 ml, 38-430, 1 Piece

4-(Pyrrolidine-1-sulfonyl)aniline, 95.0%, 5g

Di-ammonium hydrogen citrate, min. 98%, pa, ACS, 2.5 kg, plastic packaging.

ETHYL 1H-PYRAZOLO[4,3-B]PYRIDINE-6-CARBOXYLATE, 95.0%, 250mg

ETHYL 1-OXA-2-AZASPIRO[4.5]DEC-2-ENE-3-CARBOXYLATE, 95.0%, 250mg

4,5-Diamino-3-fluoro-2-phenylaminobenzoic acid methyl ester, 95.0%, 1g

Morpholine-3,4-dicarboxylic acid 4-tert-butylester, 97.0%, 1g

5-[3,5-Bis(trifluoromethyl)phenyl]-3-(chloromethyl)-1,2,4-oxadiazole, 250mg

1-(4-Fluorophenyl)-2-methylpropan-1-one, 97.0%, 100mg

3-iodo-1H-1,2,4-triazole, 95.0%, 1g